12 July 2019
Watch the sessions from our 50th anniversary conference!
Skyrizi (Risankizumab) has been recommended for the treatment of severe psoriasis in England and Wales.
This disappointing decision comes despite 65% of respondents to the consultation disagreeing with the proposal.
3 July 2019
The product has been withdrawn from manufacture due to low demand
2 July 2019
No need for a new prescription if you have an affected product, but speak to your doctor if concerned.
The Psoriasis Association is the UK's leading national charity and membership organisation for people affected by psoriasis – patients, families, carers and health professionals Read More >
The Psoriasis Association Dick Coles House 2 Queensbridge Northampton NN4 7BF
Email: mail@psoriasis-association.org.uk
© The Psoriasis Association Charitable Incorporated Organisation Number: 1180666 Scotland: SC039886 Privacy PolicyCookies
Site by Spoken Image | glitterfish
We use cookies to help us provide you with a better service, but do not track anything that can be used to personally identify you.
If you prefer us not to set these cookies, please visit our Cookie Settings page or continue browsing our site to accept them.